This site is intended for healthcare professionals only
LoginRegister
Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillationBayer unveils drug for CKD associated with diabetes under brand name Kerendia
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinationsCombinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin...
Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 croreLupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore
Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026Novartis Sandoz division to go independent
Dr Vivek Srivastava onboarded as Senior Vice President of Zeon LifesciencesDr Vivek Srivastava onboarded as Senior Vice President of Zeon Lifesciences
Lupin bags tentative USFDA nod for rare autoimmune disorder drug AmifampridineLupin, I'rom ink pact for biosimilar Denosumab
Glenmark Pharma North Carolina facility gets USFDA OAI statusGlenmark Pharma North Carolina facility gets USFDA OAI status
Drug Safety Alert: IPC flags adverse reactions linked to cephalosporin antibiotic CefoperazoneDrug Safety Alert: IPC flags adverse reactions linked to cephalosporin antibiotic Cefoperazone
Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation SolutionLupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution
COVID vaccine 73.2 percent effective in children under 5: PfizerCOVID vaccine 73.2 percent effective in children under 5: Pfizer
Bharat Biotech rotavirus oral vaccine ROTAVAC introduced in Nigeria for childrenBharat Biotech rotavirus oral vaccine ROTAVAC introduced in Nigeria for children
AstraZeneca discontinues Phase 3 trial of prostate cancer drug TruqapAstraZeneca may not stay in vaccine business in long run: CEO
X